1040723-84-9

Upstream product

• 3964-57-6 methyl 4-hydroxy-3-chlorobenzoate 
• 76-04-0 2-chloro-2,2-difluoroacetic acid 

Downstream Products

• 1192829-74-5 3-chloro-4-(difluoromethoxy)benzoic acid 
• 1192829-75-6 3-chloro-4-[(difluoromethyl)oxy]benzoyl chloride 
• 1192829-52-9 3-[5-(5-{3-chloro-4-[(difluoromethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1-isoquinolinyl]propanoic acid 
• 1192829-96-1 1,1-dimethylethyl 3-[5-(5-{3-chloro-4-[(difluoromethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1-isoquinolinyl]propanoate 

Relevant academic research and scientific papers

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS

The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can a

SYNTHESIS OF PYRAZOLES

The present invention provides methods of making HCl salts, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other

NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS

The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.